Evidence map›Paper›PMID 32462135›Full record

ArticleWater research X2020

The grey water footprint of human and veterinary pharmaceuticals.

Lara Wöhler, Gunnar Niebaum, Maarten Krol, Arjen Y Hoekstra

Open access · goldAbstract read
In one paragraph

Article in Water research X, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. [The health-environment perspective as a tool for ecopharmacovigilance].Revista de salud publica (Bogota, Colombia) · 2025
    Article
  6. Article
  7. (Antibiotic-Resistant)Environmental science & technology · 2022
    Article
  8. Human health risk assessment of pharmaceuticals in the European Vecht River.Integrated environmental assessment and management · 2022
    Article
  9. FeMaterials (Basel, Switzerland) · 2022
    Article
  10. Review
  11. Article
  12. Review
  13. Virtual Water Trade in the Service Sector: China's Inbound Tourism as a Case Study.International journal of environmental research and public health · 2021
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 3 countries.

Lara WöhlerTwente Water Centre, Faculty of Engineering Technology, University of Twente, Horst Complex Z223, P.O Box 217, 7500, AE, Enschede, Netherlands.
Gunnar NiebaumInstitute of Environmental Systems Research, Osnabrück University, Barbarastraße 12, D-49076, Osnabrück, Germany.
Maarten KrolTwente Water Centre, Faculty of Engineering Technology, University of Twente, Horst Complex Z223, P.O Box 217, 7500, AE, Enschede, Netherlands.
Arjen Y HoekstraTwente Water Centre, Faculty of Engineering Technology, University of Twente, Horst Complex Z223, P.O Box 217, 7500, AE, Enschede, Netherlands.
University of Twente · NLOsnabrück University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Water pollution by pharmaceuticals is widespread, causing both environmental and human health risks. We assess pharmaceutical water pollution from human and veterinary pharmaceuticals at three geographical levels: global, national (considering Germany and the Netherlands) and catchment level (with a case study for the Vecht catchment shared by Germany and the Netherlands). The grey water footprint (GWF), a measure of water pollution in volumetric terms, is estimated from pharmaceutical loads entering the aquatic environment, considering different pollutant sources and pathways. We study different substances depending on data availability, which varies across geographical levels. Results show a global per capita GWF of 1900 m

Indexed as

Grey water footprintHuman healthLivestockManurePharmaceuticalsWater pollution

Identifiers

PMID32462135
PMCPMC7242788
OpenAlexW3000711148

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.